The
nice people at “Transfusion News” sent their update today. Cardiothoracic
surgery, working with your neighbours, and convalescent plasma (which *might*
be useful after all…)
Machine Learning-Based Algorithm to Predict Intraoperative RBC Use during Cardiothoracic Surgery
 | | February 9, 2022 | | Cardiothoracic
surgery patients have a high risk for hemorrhage and occasionally
require massive transfusions, though most patients require 0 to 3 units
of red blood cells (RBCs). Patient blood management models commonly rely
on maximum surgical blood order schedules to avoid excessive blood
waste, but a more personalized prediction on the risk of surgical
hemorrhage and blood use would be useful to help conserve blood
resources. [Read More] |
|
 | | In
this new Transfusion Science Webinar, Benjamin Holmes, Blood
Transfusion Laboratory Manager for Pilgrim Hospital, Boston, UK, will
explain to us how a networked solution and the associated Bio-Rad
software has afforded further benefits to their organization. [Register Now] |
|
 | |
| February 2, 2022 | | Understanding
which patients with COVID-19 benefit the most from COVID-19
convalescent plasma (CCP) may help determine how convalescent plasma may
be used during future pandemics. As reported in JAMA Network Open,
researchers identified patient profiles to determine who will benefit
most from CCP. [Read More] |
|
No comments:
Post a Comment